Global Aluminum Hydroxide Market

Aluminum Hydroxide Market Size, Share, Growth Analysis, By Grade (Industrial Grade, Pharmaceutical Grade), By Form (Powder, Gel), By Application, By Region - Industry Forecast 2025-2032

Report ID: SQMIG15B2091 | Region: Global | Published Date: December, 2024
Pages: 157 | Tables: 59 | Figures: 75

Aluminum Hydroxide Market News

  • In January 2023, Huber Engineered Materials (US) announced the acquisition of the aluminum hydroxide business of Rhodia (France).
  • In February 2023, Nabaltec AG (Germany) launched a new line of high-purity aluminum hydroxide products for the pharmaceutical industry.
  • In March 2023, Albemarle Corporation (US) announced the expansion of its aluminum hydroxide production capacity in China.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Aluminum Hydroxide Market size was valued at USD 1.9 billion in 2022 and is poised to grow from USD 2.3 billion in 2023 to USD 2.94 billion by 2031, growing at a CAGR of 5% during the forecast period (2024-2031).

Aluminum Hydroxide Market Top Player’s Company Profiles 'Akrochem Corporation ', 'Albemarle Corporation ', 'American Elements ', 'Bisley & Company Pty Ltd. ', 'Hindalco Industries Limited (Aditya Birla Group) ', 'J.M. Huber Corporation ', 'Nabaltec AG ', 'Nippon Light Metal Holdings Co. Ltd. ', 'Showa Denko K. K. ', 'Sibelco ', 'Sumitomo Chemical Co. Ltd. ', 'TOR Minerals International Inc. ', 'Nikola Chemicals ', 'Tosoh ', 'ASK Chemicals ', 'Argos Therapeutics ', 'Thermo Fisher Scientific  ', 'BASF ', 'Showa Denko ', 'Nabaltec'

The pharmaceutical industry is a significant driver of the aluminum hydroxide market. Aluminum hydroxide is used as an active ingredient in antacid formulations and as an adjuvant in vaccines, contributing to the growth of the market. The rising prevalence of gastrointestinal disorders and the increasing demand for vaccines further fuel the market growth.

Rising Application in Pharmaceuticals: The pharmaceutical industry is a significant consumer of aluminum hydroxide. It is used as an active ingredient in antacid formulations and as an adjuvant in vaccines. The increasing prevalence of gastrointestinal disorders and the growing demand for vaccines are driving the demand for pharmaceutical-grade aluminum hydroxide.

Asia Pacific dominated the global aluminum hydroxide market. The Asia Pacific region has a significant share in the market due to the presence of major aluminum hydroxide manufacturers and a robust manufacturing sector. Countries such as China, Japan, and South Korea are key contributors to the regional market growth. The dominant position of Asia Pacific is attributed to the increasing demand for aluminum hydroxide in various industries, including flame retardants, ceramics, and pharmaceuticals. Additionally, the region benefits from lower production costs and a favorable regulatory environment, further supporting market dominance.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Aluminum Oxide Market
Buy Now GET FREE SAMPLE
Sodium Hydroxide Market
Buy Now GET FREE SAMPLE
Aluminum Market
Buy Now GET FREE SAMPLE
Magnesium Hydroxide Market
Buy Now GET FREE SAMPLE
Alumina Market
Buy Now GET FREE SAMPLE
Beryllium Hydroxide Market
Buy Now GET FREE SAMPLE
Activated Alumina Market
Buy Now GET FREE SAMPLE
High Purity Alumina Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Aluminum Hydroxide Market

Report ID: SQMIG15B2091

$5,300
BUY NOW GET FREE SAMPLE